|
Q3 2021
Filed on Nov 04, 2021
|
617
|
$243.18 - $263.44
$150K - $163K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,289
|
$24.0 - $28.9
$54.9K - $66.2K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
32,562
|
$60.28 - $65.6
$1.96M - $2.14M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,069
|
$37.47 - $40.44
$77.5K - $83.7K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,804
|
$48.12 - $48.7
$135K - $137K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
543
|
$102.77 - $112.89
$55.8K - $61.3K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
3,300
|
$60.41 - $66.23
$199K - $219K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
195
|
$33.65 - $37.93
$6.56K - $7.4K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
1,489
|
$179.22 - $189.21
$267K - $282K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
6,961
|
$151.62 - $161.28
$1.06M - $1.12M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
12,012
|
$67.76 - $72.0
$814K - $865K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
4,527
|
$199.12 - $212.29
$901K - $961K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
3,405
|
$107.56 - $118.12
$366K - $402K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
16,547
|
$12.54 - $20.31
$207K - $336K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
14,774
|
$74.23 - $78.13
$1.1M - $1.15M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
3,550
|
$74.65 - $80.95
$265K - $287K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
4,512
|
$66.91 - $71.05
$302K - $321K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
1,472
|
$51.32 - $54.83
$75.5K - $80.7K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
39,387
|
$101.91 - $102.02
$4.01M - $4.02M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
41,699
|
$2.21 - $2.89
$92.2K - $121K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
34,000
|
$2.06 - $5.34
$70K - $182K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
500,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
68,000
|
$1.22 - $2.0
$83K - $136K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
35,230
|
$2.17 - $4.07
$76.4K - $143K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
6,212
|
N/A
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
100
|
$4.81 - $24.14
$481 - $2.41K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,440
|
$55.5 - $58.86
$135K - $144K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,757
|
$50.02 - $55.63
$138K - $153K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
71,761
|
$62.25 - $63.89
$4.47M - $4.58M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
22,834
|
$51.65 - $51.91
$1.18M - $1.19M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
534
|
$20.91 - $23.53
$11.2K - $12.6K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
193
|
$58.62 - $63.49
$11.3K - $12.3K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
134
|
$47.05 - $53.78
$6.3K - $7.21K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
1,987
|
$11.31 - $13.81
$22.5K - $27.4K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
38,659
|
$50.45 - $50.5
$1.95M - $1.95M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
27,143
|
N/A
|
|
Constellation Pharmceticls I
|
Q3 2021
Filed on Nov 04, 2021
|
23,515
|
N/A
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,900
|
$0.93 - $1.18
$2.7K - $3.42K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
98,340
|
$1.89 - $2.51
$186K - $247K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
145,901
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q3 2021
Filed on Nov 04, 2021
|
10,374
|
N/A
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
26,258
|
$100.08 - $100.11
$2.63M - $2.63M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
3,568
|
$9.56 - $11.67
$34.1K - $41.6K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
2,299
|
$62.71 - $69.78
$144K - $160K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
104
|
$3.67 - $5.8
$382 - $603
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
24,464
|
$50.52 - $50.94
$1.24M - $1.25M
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
6,836
|
$32.62 - $34.39
$223K - $235K
|
|
Inotek Pharmaceuticals Corp
|
Q3 2021
Filed on Nov 04, 2021
|
4,000,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
9,434
|
$19.42 - $19.67
$183K - $186K
|
|
|
Q3 2021
Filed on Nov 04, 2021
|
1,262
|
$51.33 - $51.63
$64.8K - $65.2K
|
|